Expanding Early Intensive Treatment Beyond Glycemia in Type 2 Diabetes
(MedPage Today) -- At the American Diabetes Association annual meeting, findings from the SURPASS-EARLY trial added to growing evidence that treating type 2 diabetes aggressively from the time of…
Read the full articleYou might also wanna read
Guidance Aids Adjunctive Incretin Use in Type 1 Diabetes
Positive findings from a phase 2 trial were followed by disappointing news; however, new guidelines aim to help clinicians with off-label pr
What's new in diabetes research
Ruth Weinstock, MD, PhD Ruth Weinstock, MD, PhD (photo by Jim Howe) (photo by Jim Howe) Some medications that work for adults with type 2 di
Advances in Automated Insulin Delivery Systems for Type 2 Diabetes Management
Discover the latest advances in automated insulin delivery for type 2 diabetes. Explore expert-led CME activities designed to help you optim
mdsc.pe·23d ago
ADA 2026 Scientific Sessions: New GLP-1 Drugs and Diabetes Research Highlights
Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity resea
ja.ma·26d agoGLP-1 vs SGLT2: The New Frontier in Diabetes Therapy
A new commentary in The Lancet examines whether oral GLP-1 receptor agonists can match SGLT2 inhibitors in cardiovascular and kidney protect
GLP-1 Agonists May Help People With Diabetes and Long COVID
People with type 2 diabetes face increased risk of severe lung conditions. A new study reported that mice treated with GLP-1agonists showed
Comments
Sign in to join the conversation.
No comments yet. Be the first.